Conference Coverage
Trending on Contemporary OB/GYN
HRSA updates cervical cancer screening guidelines
Study: No independent diabetes risk linked to timing, type of menopause
Differences in pregnancy-related hypertension risk across Asian and Pacific Islander subgroups
Minimum wage increases linked to lower rates of maternal hypertensive disorders
LPCN 1154 for postpartum depression continues clinical process after safety review
Latest News
Shorts










Podcasts

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD
In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2
This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1
This is part 1 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Recap on reproductive rights with David Hackney, MD, MS
In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.

Pap Talk: Bonus episode S4E11: EMIGS with Dr. Nash Moawad
In this bonus episode, Nash Moawad, MD, MS, FACOG, FACS, sits down to discuss the recent standardization of Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program for minimally invasive gynecologic surgeons and how it's shaping the way this subspecialty delivers care.

Pap Talk S4E10: 2023 women's health outlook
In this episode of Pap Talk, Alison Cowan, MD, discusses her predictions for women's health trends in 2023.

Pap Talk: The impact of environmental exposures on women's health
From safe baby products to helping your patients become educated consumers, Huffling's insights are valuable across practices.

Pap Talk: Medications for early pregnancy loss with Amy Levi, CNM, WHNP-BC, FACNM, FAAN
Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Pap Talk: Medications for early pregnancy loss
In this episode of Pap Talk, Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition
Tune into this valuable discussion with host Scott Kober and experts Rachel Pope, MD, MPH, and Sheryl Kingsberg, PhD, as they highlight the overall impact of vaginismus and discuss strategies to combat its effects on women who are diagnosed the condition.
Continuing Medical Education
All News

New data suggest that diabetes risk after menopause is driven by cardiometabolic factors rather than when or how menopause occurs.

A large California cohort study shows that aggregating Asian American and Pacific Islander populations can obscure substantial differences in hypertensive disorder risk during pregnancy.

New HRSA guidelines strengthen cervical cancer prevention by adding self-collected hrHPV testing and clarifying no-cost coverage for additional diagnostic services.

Analysis of internal FDA records reveals that mifepristone’s REMS program was shaped by repeated evidence-based safety reviews.

Gestational diabetes rates have increased by 36% in the United States since 2016, with consistent rises across racial and ethnic groups.

In a recent study, improved postpartum blood pressure control was associated with increased white matter brain volume after hypertensive pregnancy.

A study found that adding low-dose megestrol acetate to standard anti-oestrogen therapy significantly reduced tumor proliferation in women with breast cancer.

A cost-effectiveness model found first-line IV iron dextran offers higher value than oral iron for IDA in women with heavy menstrual bleeding.

A study found higher remnant cholesterol levels are independently associated with increased odds of endometriosis.

Maternal influenza and Tdap vaccination during pregnancy was associated with fewer influenza- and pertussis-related hospital and ED visits in infants younger than 6 months.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A study found that opioid use during pregnancy is associated with significantly increased maternal complications and adverse neonatal outcomes.

A study found distinct alterations in vaginal and gut microbial composition and function among patients with endometriosis.

New evidence shows that quadrivalent HPV vaccination is associated with a significant reduction in vulvar and vaginal lesion risk.

New research shows COVID-19 vaccination before or during pregnancy significantly lowers the risk of severe maternal illness and reduces rates of preterm birth.

Screen-guided care using the PreTRM blood test reduced preterm birth–related complications and NICU use.

A study found that distinct cervicovaginal microbial patterns are linked to the success of frozen embryo transfer in endometriosis patients.

A study found gestational diabetes prevalence has increased steadily across all racial and ethnic groups over the past decade.

A systematic review found AI-assisted ultrasound models improved diagnostic accuracy for endometriosis, with deep learning outperforming traditional methods.

A study found that risk-stratified planned early-term delivery significantly lowers preeclampsia incidence without increasing cesarean birth.

New guidelines provide recommendations for adjusting antiseizure medication doses during pregnancy and postpartum to support healthy outcomes.

New research links abnormal collagen remodeling at cesarean scars—not placental invasion—to placenta accreta spectrum risk.

A study links opioid-related diagnoses during pregnancy to increased maternal morbidity and neonatal complications.

A study found no clear evidence that menopause hormone therapy increases or reduces dementia risk.

Criteria-independent genetic testing identifies more women with pathogenic breast cancer variants than guideline-based approaches.

A study found that an investigational α-lactalbumin–targeting vaccine induced immune responses in 74% of participants at risk for triple-negative breast cancer.

A study found HPV vaccination is linked to reduced odds of severe vulvar and vaginal precancerous lesions.

New research shows that COVID-19 vaccination in pregnancy significantly lowers the risk of hospitalization and preterm delivery.

Take a quick look at everything you may have missed during the fourth quarter of 2025, including the latest FDA approvals and top stories.

Check out the biggest approvals in women's health during 2025.

Take a quick look at everything you may have missed in December, including the latest FDA updates, top stories, and expert recommendations.

Take a quick look at everything you may have missed in 2025, including the latest FDA updates, top stories, and expert recommendations.

Check the top women's health conferences of 2025.



























